News Information
Focusing on cutting-edge technology and conveying industry voices
The rapid advancement of AI-driven drug discovery is driving an exponential surge in demand for high-quality molecular interaction data. However, traditional protein‑production methods suffer from low throughput and lengthy assay cycles, making them the most significant bottleneck between wet‑lab experiments and AI models. How can we achieve end-to-end automation, spanning rapid protein preparation to high‑throughput affinity screening? And how can we ensure that wet‑lab assays deliver high‑quality inputs that meet the data‑hungry requirements of AI systems?
2026/06/17
Cell-free expression opens new avenues for studying membrane protein function.
Perotin Bio, leveraging its proprietary cell-free protein expression platform, has established a comprehensive product portfolio ranging from assay kits to end-to-end membrane protein expression services. By incorporating folding‑assisting factors such as nanodiscs and detergents into the expression system, the company effectively enhances the solubility and functional activity of challenging membrane proteins, including multi‑transmembrane receptors, transporters, and ion channels. The company has achieved expression levels and activity at structural‑resolution quality for numerous membrane protein targets, significantly shortening the R&D cycle for research clients—from gene to functional protein.
2026/07/09
Membrane Protein Expression: Overcoming the Bottlenecks through Cell-Free Systems
In protein expression research, membrane proteins have long been notorious for their high failure rates. Despite highly mature optimization strategies—such as expression vector engineering, codon optimization, and host system screening—actual R&D pipelines frequently stall at the same frustrating stage: the inability to obtain stable, high-yield expression products.
2026/07/03
July 24–26, 2026 (full-day registration on the 24th) Nanjing City, Jiangsu Province (Guangyuan Holiday Hotel ★★★★★), Intersection of Binhu West Road and Innovation Middle Road, Jiangning District, Nanjing
2026/06/17
Want to stand out in top-tier biology competitions like iGEM (International Genetically Engineered Machine Competition), but feel held back by the tediousness, time‑consuming nature, and high barriers of traditional cell‑based experiments? The PLD Cell‑Free Protein Expression Kit (PLDK003) is designed for biology education and competitions at every stage—from high school through undergraduate and graduate studies. With its ultra‑simple operation, rapid results, and exceptional versatility, it helps your project get ahead and shine!
2026/06/17
Applications and Future Trends of Cell-Free Protein Expression Technology
Cell-Free Protein Synthesis (CFPS) has grown rapidly in the fields of synthetic and structural biology in recent years. It is steadily evolving from a basic laboratory tool into a vital technology platform for protein engineering and drug discovery. The core of this technology lies in the in vitro reconstitution of transcription and translation systems, enabling the rapid synthesis of target proteins while completely bypassing the complex regulatory networks found inside living cells.
2026/06/10
In protein engineering and antibody–drug conjugate (ADC) research, achieving “precise site-specific modification” of proteins has long been a critical scientific challenge. Traditional protein‑modification strategies typically rely on random reactions with the side chains of natural amino acids, leading to inherent uncertainties in modification sites, modification ratios, and product heterogeneity—factors that significantly impact both functional studies and drug development. In recent years, a biological strategy based on Genetic Code Expansion (GCE) has gained increasing attention. By reprogramming the protein translation machinery, this approach incorporates non‑natural amino acids at predefined codon positions during protein synthesis, enabling precise structural design of proteins at the expression stage. Unlike conventional methods that depend on post‑translational modifications, GCE shifts the control point upstream to the protein biosynthesis process itself, transforming protein modification from a stochastic event into a programmable, translational‑level process. This dramatically enhances the specificity and consistency of site‑directed modifications. This strategy offers a more precise and controllable biological platform for applications such as antibody–drug conjugation, protein labeling, and the design of functional proteins. In this live session, we will explore the principles and applications of site‑specific incorporation of non‑natural amino acids, highlighting their significance in ADC development and protein engineering.
2026/06/10
On the morning of May 20, the technical team of Suzhou Perotin Biotechnology Co., Ltd. paid an invited visit to the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, where they delivered a special report on “Cell-Free Protein Expression Technology and Recent Advances in Its Applications.” Key researchers and graduate student representatives from the institute attended the event, and the ensuing discussions were both substantive and in-depth.
2026/05/29
On June 4–5, the 2026 Pharma Future Summit will grandly open at the Kempinski Hotel Suzhou Jinji Lake. This year’s summit adopts a holistic, full‑industry‑chain perspective, bringing together top decision‑makers to build a closed-loop, collaborative ecosystem. It focuses on breaking through barriers in the industrialization of cutting-edge technologies and on global strategic planning, reshaping the paradigm of pharmaceutical innovation and collaboration. Sub‑Venue 7: AI Session Keynote Topic 1: “The Revolution of AI in Drug Discovery” Cui Jinhui, CEO of Suzhou Perotin Bio: “Generative AI Coupled with Cell-Free Protein Expression: Empowering Innovation at the Source of Drug Development” 📍June 4–5, Kempinski Hotel Suzhou Jinji Lake
2026/05/28
Contact Information
Service Hotline: +86-512-67900128
Customer Service: order@sz-pld.tech
Business Cooperation: bd@sz-pld.tech
Address: Room 302, Building 1, Weili Medical Science and Technology Park, No. 69 Jiepu Road, Suzhou Industrial Park
